Dr. Daniel M. Halperin, MD

Dr. Halperin practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Halperin's NPI, 1801024161, was assigned on June 25, 2009. Dr. Halperin holds Texas license Q2672.

Dr. Halperin's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Halperin's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Halperin is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Halperin to 1 more hospital and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halperin practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Halperin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Halperin is licensed in Texas.

CMS data shows 184 Medicare services from Dr. Halperin across 3 procedure codes in 2024, all of them office visits, for 145 Medicare patients. Medicare paid $13,697 for them.

CMS counts 145 Medicare patients who saw Dr. Halperin in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 3.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Halperin's median patient age at 69, with 54% women.

In 2024, Dr. Halperin wrote 47 Medicare Part D claims for 22 patients. 72% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $78,497 in total drug cost. In 2020, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Halperin for performance year 2024, reported through an alternative payment model (APM). Dr. Halperin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 131 general payments to Dr. Halperin from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Exelixis Inc. paid the most, $21,380. It also lists 19 research payments totaling $14,117 from 2016 to 2025.